{"article_title": "Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous Misadventure", "article_keywords": ["development", "misadventure", "dangerous", "research", "sovaldi", "costs", "gileads", "politicizing", "reckless"], "article_url": "http://www.forbes.com/sites/theapothecary/2014/07/25/politicizing-gileads-research-and-development-costs-for-sovaldi-is-a-reckless-and-dangerous-misadventure/", "article_text": "", "article_metadata": {"description": "Gilead has become the whipping boy du jour for the forthcoming Obamacare-driven cost explosion in health spending. Politicians and the health-insurance industry have embarked on a high-profile campaign to shame Gilead for the price of its new wonder-drug, Sovaldi. If successful, this campaign will have terrible long-term consequences for medical innovation.", "author": "The Apothecary", "og": {"site_name": "Forbes", "description": "Gilead has become the whipping boy du jour for the forthcoming Obamacare-driven cost explosion in health spending. Politicians and the health-insurance industry have embarked on a high-profile campaign to shame Gilead for the price of its new wonder-drug, Sovaldi. If successful, this campaign will have terrible long-term consequences for medical innovation.", "title": "Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous Misadventure", "url": "http://www.forbes.com/sites/theapothecary/2014/07/25/politicizing-gileads-research-and-development-costs-for-sovaldi-is-a-reckless-and-dangerous-misadventure/", "image": "http://blogs-images.forbes.com/theapothecary/files/2014/07/670px-obama_signing_health_care-201003231.jpg", "updated_time": "2014-07-25T17:52:02-04:00", "type": "article"}, "twitter": {"description": "Gilead has become the whipping boy du jour for the forthcoming Obamacare-driven cost explosion in health spending. Politicians and the health-insurance industry have embarked on a high-profile campaign to shame Gilead for the price of its new wonder-drug, Sovaldi. If successful, this campaign will have terrible long-term consequences for medical innovation.", "creator": "@forbesopinion", "image": "http://blogs-images.forbes.com/theapothecary/files/2014/07/670px-obama_signing_health_care-201003231.jpg", "title": "Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous Misadventure", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Healthcare  Fiscal,Pharma and Health,Policy,Powering Productivity,Washington,healthcare,Healthcare &amp; Fiscal,Pharma &amp; Healthcare", "article": {"publisher": "https://www.facebook.com/forbes", "author": "http://www.facebook.com/https://www.facebook.com/forbesaroy", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2014-07-25", "published": "2014-07-25", "id": "blogAndPostId/blog/post/1314-20752"}, "news_keywords": "Business,Healthcare  Fiscal,Pharma and Health,Policy,Powering Productivity,Washington,healthcare,Healthcare &amp; Fiscal,Pharma &amp; Healthcare", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}